Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Receivables (2021 - 2025)

Historic Receivables for Pulse Biosciences (PLSE) over the last 3 years, with Q3 2025 value amounting to $15000.0.

  • Pulse Biosciences' Receivables changed N/A to $15000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $15000.0, marking a year-over-year change of. This contributed to the annual value of $61000.0 for FY2021, which is N/A changed from last year.
  • Pulse Biosciences' Receivables amounted to $15000.0 in Q3 2025.
  • Pulse Biosciences' Receivables' 5-year high stood at $72000.0 during Q3 2021, with a 5-year trough of $5000.0 in Q3 2022.
  • For the 3-year period, Pulse Biosciences' Receivables averaged around $30333.3, with its median value being $18000.0 (2022).
  • Over the last 5 years, Pulse Biosciences' Receivables had its largest YoY gain of 9305.56% in 2022, and its largest YoY loss of 9305.56% in 2022.
  • Pulse Biosciences' Receivables (Quarter) stood at $61000.0 in 2021, then tumbled by 91.8% to $5000.0 in 2022, then soared by 200.0% to $15000.0 in 2025.
  • Its Receivables was $15000.0 in Q3 2025, compared to $5000.0 in Q3 2022 and $8000.0 in Q2 2022.